Alpha‐2 Agonist Adulterants Are Not Associated With Prolonged Sedation in Emergency Department Opioid Overdose
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1: acem70241-sup-0001-Supinfo.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Stephanie Abston (ORCID: https://orcid.org/0009-0001-1024-8582)
- Rachel Culbreth (ORCID: https://orcid.org/0000-0002-5270-2608)
- Joshua A. Shulman
- Alexandra Amaducci
- Joseph Carpenter (ORCID: https://orcid.org/0000-0001-5487-6671)
- Diane P. Calello (ORCID: https://orcid.org/0000-0003-1752-847X)
- Barry Kerr Logan (ORCID: https://orcid.org/0000-0003-2400-4711)
- Jennifer S. Love (ORCID: https://orcid.org/0000-0002-5882-4390)
- J. Brent
- Shao Li
- Alex F. Manini
- Paul Wax
- Sharan Campleman
- Kim Aldy
- Alex Krotulski
- Evan Schwarz
- Jennie Buchanan
- Adrienne Hughes
- Michael Levine
- Christopher Meaden
- Bryan Judge
Institutions
- Rutgers, The State University of New Jersey (US)
- Lehigh Valley Hospital-Pocono (US)
- Emory University (US)
- University of California, Los Angeles (US)
- Oregon Health & Science University (US)
- University of Pittsburgh (US)
- Denver Health Medical Center (US)
- Lehigh Valley Health Network (US)
- Elmhurst Hospital Center (US)
- Fredric Rieders Family Foundation (US)
- Rutgers New Jersey Medical School (US)
- American College of Medical Toxicology (US)
- Michigan State University (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Academic Emergency Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/acem.70241
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute on Drug Abuse